logo

For the Inventor, By the Inventor

Salt Lake City, UT, United States of America

Gaylen M Zentner

This inventor holds 17 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 1 EPO patent, primarily in Biodegradable Polymers. Top assignees: Macromed Incorporated, Protherics Salt Lake City, Inc., Sarcos Lc. Active years: 1998-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gaylen M Zentner. Retrieved from https://idiyas.com/inventor/gaylen-m-zentner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 94.1



Average Co-Inventor Count = 2.5

ph-index = 11

Forward Citations = 1,707(Granted Patents)


Company Filing History:

goldMedal10 out of 16 
 
Macromed Incorporated
 patents
silverMedal2 out of 4 
 
Protherics Salt Lake City, Inc.
 patents
bronzeMedal2 out of 73 
 
Sarcos Lc
 patents
4. 1 out of 3 
 
Aesica Pharmaceuticals Limited
 patents
5. 1 out of 3,978 
 
Novartis Ag
 patents
6. 1 out of 82 
 
Sarcos Corp.
 patents

Years Active: 1998-2016

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Drug Delivery
Biodegradable Polymers
Polymer Blends
Controlled Release
Biocompatible Particles
PLA/PLGA Oligomers
Microencapsulation
Pharmaceutical Compositions
Thermal Gelation
Automatic Dosing
Microparticles
Bioactive Agents
17 patents (USPTO):Explore Patents
1. 9265836 - Biodegradable block copolymeric compositions for drug delivery (2016-02-23),
2. 8653139 - Drug substance preparations, pharmaceutical compositions and dosage forms (2014-02-18),
3. 8642666 - Biodegradable block copolymeric compositions for drug delivery (2014-02-04),
4. 7649023 - Biodegradable block copolymeric compositions for drug delivery (2010-01-19),
5. 7182957 - Polymer blends that swell in an acidic environment and deswell in a basic environment (2007-02-27),
6. 6998137 - Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix (2006-02-14),
7. 6730327 - Polymer blends that swell in an acidic environment and deswell in a basic environment (2004-05-04),
8. 6592899 - PLA/PLGA oligomers combined with block copolymers for enhancing solubility of a drug in water (2003-07-15),
9. 6589549 - Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles (2003-07-08),
10. 6537584 - Polymer blends that swell in an acidic environment and deswell in a basic environment (2003-03-25),
11. 6287588 - Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof (2001-09-11),
12. 6201072 - Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties (2001-03-13),
13. 6117949 - Biodegradable low molecular weight triblock poly (lactide-co-glycolide) (2000-09-12),
14. 6056734 - Method for automatic dosing of drugs (2000-05-02),
15. 6010492 - Apparatus for automatic administration of multiple doses of drugs (2000-01-04),

Title: Innovative Contributions of Gaylen M. Zentner

Introduction

Gaylen M. Zentner, an esteemed inventor based in Salt Lake City, UT, has made significant strides in the field of drug delivery through his innovative research and development. With a remarkable portfolio of 17 patents, he continues to push the boundaries of pharmaceutical compositions and their applications, showcasing his commitment to advancing healthcare.

Latest Patents

Zentner's latest patents highlight his expertise in creating groundbreaking drug delivery systems. One of his most notable inventions is the "Biodegradable Block Copolymeric Compositions for Drug Delivery." This advanced composition features one or more biodegradable block copolymer drug carriers combined with a reconstitution enhancing and enabling agent that comprises polyethylene glycol (PEG) or its derivatives. This formulation allows for administration as a homogeneous solution or uniform colloidal systems, significantly improving the efficacy of drug delivery.

Additionally, his patent on "Drug Substance Preparations, Pharmaceutical Compositions and Dosage Forms" focuses on a specific active pharmaceutical ingredient, (R)-(-)-2-(2-fluoro-4-biphenylyl) propionic acid. This invention emphasizes the importance of minimizing product-related and process-related impurities, ensuring that the pharmaceutical compositions are both safe and effective.

Career Highlights

Throughout his career, Gaylen M. Zentner has contributed to various organizations, including Macromed Incorporated and Sarcos LC. His innovative approaches and dedication to pharmaceutical research have not only garnered numerous patents but have also positioned him as a leading figure in drug delivery technologies.

Collaborations

Zentner has worked alongside esteemed colleagues such as Chung Shih and Ramesh C. Rathi. These collaborations have fostered a dynamic exchange of ideas and have significantly contributed to the success of his projects, ultimately leading to important advancements in pharmaceutical sciences.

Conclusion

In summary, Gaylen M. Zentner's inventive spirit and contributions to drug delivery are noteworthy. His 17 patents reflect a profound understanding of pharmacology and innovative design, paving the way for new therapeutic solutions in healthcare. As he continues to explore the potential of biodegradable compositions and improved drug delivery methods, the impact of his work will resonate within the pharmaceutical industry for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…